QurieGen
4 known investors
QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.
Investors · 4
Competitors · 2
by search overlap
Pixelgen3 shared keywordsPixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
Vizgen3 shared keywordsVizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.
Companies competing with QurieGen for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does QurieGen do?
- QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.
- Who are QurieGen's investors?
- QurieGen's investors include BSV Ventures, Draper Associates, Lighthouse Ventures, Tensor Ventures.